These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

652 related items for PubMed ID: 27998624

  • 1. Warfarin Initiation, Atrial Fibrillation, and Kidney Function: Comparative Effectiveness and Safety of Warfarin in Older Adults With Newly Diagnosed Atrial Fibrillation.
    Jun M, James MT, Ma Z, Zhang J, Tonelli M, McAlister FA, Manns BJ, Ravani P, Quinn RR, Wiebe N, Perkovic V, Wilton SB, Winkelmayer WC, Hemmelgarn BR, Alberta Kidney Disease Network.
    Am J Kidney Dis; 2017 Jun; 69(6):734-743. PubMed ID: 27998624
    [Abstract] [Full Text] [Related]

  • 2. Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study.
    Jun M, Scaria A, Andrade J, Badve SV, Birks P, Bota SE, Campain A, Djurdjev O, Garg AX, Ha J, Harel Z, Hemmelgarn B, Hockham C, James MT, Jardine MJ, Levin A, McArthur E, Ravani P, Shao S, Sood MM, Tan Z, Tangri N, Whitlock R, Gallagher M.
    Eur Heart J Qual Care Clin Outcomes; 2023 Sep 12; 9(6):621-631. PubMed ID: 36302143
    [Abstract] [Full Text] [Related]

  • 3. The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study.
    Jun M, James MT, Manns BJ, Quinn RR, Ravani P, Tonelli M, Perkovic V, Winkelmayer WC, Ma Z, Hemmelgarn BR, Alberta Kidney Disease Network.
    BMJ; 2015 Feb 03; 350():h246. PubMed ID: 25647223
    [Abstract] [Full Text] [Related]

  • 4. Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation.
    Carrero JJ, Evans M, Szummer K, Spaak J, Lindhagen L, Edfors R, Stenvinkel P, Jacobson SH, Jernberg T.
    JAMA; 2014 Mar 05; 311(9):919-28. PubMed ID: 24595776
    [Abstract] [Full Text] [Related]

  • 5. Comparative Safety and Effectiveness of Warfarin or Rivaroxaban Versus Apixaban in Patients With Advanced CKD and Atrial Fibrillation: Nationwide US Cohort Study.
    Fu EL, Desai RJ, Paik JM, Kim DH, Zhang Y, Mastrorilli JM, Cervone A, Lin KJ.
    Am J Kidney Dis; 2024 Mar 05; 83(3):293-305.e1. PubMed ID: 37839687
    [Abstract] [Full Text] [Related]

  • 6. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
    Bonde AN, Lip GY, Kamper AL, Hansen PR, Lamberts M, Hommel K, Hansen ML, Gislason GH, Torp-Pedersen C, Olesen JB.
    J Am Coll Cardiol; 2014 Dec 16; 64(23):2471-82. PubMed ID: 25500231
    [Abstract] [Full Text] [Related]

  • 7. Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and Canada.
    Ha JT, Scaria A, Andrade J, Badve SV, Birks P, Bota SE, Campain A, Djurdjev O, Garg AX, Harel Z, Hemmelgarn B, Hockham C, James MT, Jardine MJ, Lam D, Levin A, McArthur E, Ravani P, Shao S, Sood MM, Tan Z, Tangri N, Whitlock R, Gallagher M, Jun M.
    Kidney Med; 2023 Jul 16; 5(7):100675. PubMed ID: 37492112
    [Abstract] [Full Text] [Related]

  • 8. Cardiorenal Outcomes Among Patients With Atrial Fibrillation Treated With Oral Anticoagulants.
    Trevisan M, Hjemdahl P, Clase CM, de Jong Y, Evans M, Bellocco R, Fu EL, Carrero JJ.
    Am J Kidney Dis; 2023 Mar 16; 81(3):307-317.e1. PubMed ID: 36208798
    [Abstract] [Full Text] [Related]

  • 9. Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction.
    Szummer K, Gasparini A, Eliasson S, Ärnlöv J, Qureshi AR, Bárány P, Evans M, Friberg L, Carrero JJ.
    J Am Heart Assoc; 2017 Mar 01; 6(3):. PubMed ID: 28249846
    [Abstract] [Full Text] [Related]

  • 10. Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation.
    Shin JI, Secora A, Alexander GC, Inker LA, Coresh J, Chang AR, Grams ME.
    Clin J Am Soc Nephrol; 2018 Aug 07; 13(8):1144-1152. PubMed ID: 30002224
    [Abstract] [Full Text] [Related]

  • 11. Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation.
    Shen JI, Montez-Rath ME, Lenihan CR, Turakhia MP, Chang TI, Winkelmayer WC.
    Am J Kidney Dis; 2015 Oct 07; 66(4):677-88. PubMed ID: 26162653
    [Abstract] [Full Text] [Related]

  • 12. Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults.
    Kühn A, van der Giet M, Kuhlmann MK, Martus P, Mielke N, Ebert N, Schaeffner ES.
    Am J Kidney Dis; 2021 Mar 07; 77(3):386-396.e1. PubMed ID: 33197533
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial.
    Hohnloser SH, Hijazi Z, Thomas L, Alexander JH, Amerena J, Hanna M, Keltai M, Lanas F, Lopes RD, Lopez-Sendon J, Granger CB, Wallentin L.
    Eur Heart J; 2012 Nov 07; 33(22):2821-30. PubMed ID: 22933567
    [Abstract] [Full Text] [Related]

  • 14. Stroke, Major Bleeding, and Mortality Outcomes in Warfarin Users With Atrial Fibrillation and Chronic Kidney Disease: A Meta-Analysis of Observational Studies.
    Dahal K, Kunwar S, Rijal J, Schulman P, Lee J.
    Chest; 2016 Apr 07; 149(4):951-9. PubMed ID: 26378611
    [Abstract] [Full Text] [Related]

  • 15. Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation.
    Jacobs V, May HT, Bair TL, Crandall BG, Cutler MJ, Day JD, Mallender C, Osborn JS, Stevens SM, Weiss JP, Woller SC, Bunch TJ.
    Am J Cardiol; 2016 Jul 15; 118(2):210-4. PubMed ID: 27236255
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) trial analysis.
    Hijazi Z, Hohnloser SH, Oldgren J, Andersson U, Connolly SJ, Eikelboom JW, Ezekowitz MD, Reilly PA, Siegbahn A, Yusuf S, Wallentin L.
    Circulation; 2014 Mar 04; 129(9):961-70. PubMed ID: 24323795
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation.
    Winkelmayer WC, Liu J, Setoguchi S, Choudhry NK.
    Clin J Am Soc Nephrol; 2011 Nov 04; 6(11):2662-8. PubMed ID: 21959598
    [Abstract] [Full Text] [Related]

  • 18. Clinical Outcomes of Warfarin Initiation in Advanced Chronic Kidney Disease Patients With Incident Atrial Fibrillation.
    Agarwal MA, Potukuchi PK, Sumida K, Naseer A, Molnar MZ, George LK, Koshy SK, Streja E, Thomas F, Kalantar-Zadeh K, Kovesdy CP.
    JACC Clin Electrophysiol; 2020 Dec 14; 6(13):1658-1668. PubMed ID: 33334444
    [Abstract] [Full Text] [Related]

  • 19. Kidney, Cardiac, and Safety Outcomes Associated With α-Blockers in Patients With CKD: A Population-Based Cohort Study.
    Hundemer GL, Knoll GA, Petrcich W, Hiremath S, Ruzicka M, Burns KD, Edwards C, Bugeja A, Rhodes E, Sood MM.
    Am J Kidney Dis; 2021 Feb 14; 77(2):178-189.e1. PubMed ID: 32920153
    [Abstract] [Full Text] [Related]

  • 20. Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population based study from UK primary care.
    Kumar S, de Lusignan S, McGovern A, Correa A, Hriskova M, Gatenby P, Jones S, Goldsmith D, Camm AJ.
    BMJ; 2018 Feb 14; 360():k342. PubMed ID: 29444881
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.